Kensuke Shimizu

Mr. Kensuke Shimizu

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2024 in Biology
Verified
Journal Article
Open access
PDF file
Tsukasa TominariTsukasa Tominari
Tsukasa Tominari
CMChiho Matsumoto
Chiho Matsumoto
YTYuki Tanaka
Yuki Tanaka
KSKensuke Shimizu
Kensuke Shimizu
MTMasaru TAKATOYA
Masaru TAKATOYA
MIMasaki Inada
Masaki Inada
Toll-like receptors (TLRs) are pattern recognition receptors expressed in immune cells, including neutrophils, macrophages, and dendritic cells. Microbe-associated molecular patterns, including bacterial components, membranes, nucleic acids, and flagella are recognized by TLRs in inflammatory immune responses. Periodontal disease is an inflammatory disease known to cause local infections associated with gingival inflammation, subsequently leading to alveolar bone resorption. Prostaglandin E2 (PGE2) is a key mediator of TLR-induced inflammatory bone resorption. We previously reported that membrane-bound PGE synthase (mPGES-1)-deficient mice failed to induce bone resorption by lipopolysaccharide (LPS), a major pathogenic factor involved in periodontal bone resorption. Further experiments exploring specific pathogen-promoting osteoclast differentiation revealed that various TLR ligands induced osteoclast differentiation in a co-culture model. The ligands for TLR2/1, TLR2/6, TLR3, and TLR5, as well as TLR4, induce osteoclast differentiation associated with the production of PGE2 and the receptor activator of nuclear factor-kappa B ligand (RANKL), an inevitable inducer of osteoclast differentiation in osteoblasts. In vivo, local injection of TLR ligands, including TLR2/1, TLR2/6, and TLR3, resulted in severe alveolar bone resorption. This review summarizes the latest findings on TLR-mediated osteoclast differentiation and bone resorption in inflammatory diseases, such as periodontal diseases.

14 November 2025 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
MSMoe Sugasaki
Moe Sugasaki
KIKeisuke Ikeda
Keisuke Ikeda
AFAyaka Furukawa
Ayaka Furukawa
KWKenta Watanabe
Kenta Watanabe
UKUrara Kasuga
Urara Kasuga
MIMasaki Inada
Masaki Inada